PD1 longitudinal study
Research payments
$2,001,980
Through program year 2023, $2,001,980 in research payments was reported against PD1 longitudinal study, across 75 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $35,303 | 5 |
| 2022 | Research | $455,732 | 8 |
| 2019 | Research | $1,510,946 | 62 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Susanna Ulahannan Ponca City, OK Named on 11 payments
- Todd Gersten Wellington, FL Named on 11 payments
- Deepak Kilari Milwaukee, WI Named on 10 payments
- Edward Arrowsmith Chattanooga, TN Named on 9 payments
- Maen Hussein Leesburg, FL Named on 9 payments
- Ivor Percent Port Charlotte, FL Named on 6 payments
- Razelle Kurzrock Houston, TX Named on 5 payments
- Johanna Bendell Nashville, TN Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.